Literature DB >> 32728360

The influence of epicardial and endocardial use of cryoenergy on the completeness of lesions in surgical ablation of atrial fibrillation.

Vojtech Kurfirst1, Julia Csanady1, Ales Mokracek1, Jiri Hanis1, Alan Bulava1, Ladislav Pesl1.   

Abstract

INTRODUCTION: Cryoenergy is the most commonly used method of lesion formation in patients who have undergone surgical ablation of atrial fibrillation. Despite frequent use, the clinical effect of cryoenergy in endocardial and epicardial approaches is unknown. AIM: To compare the effect of various cryoenergy applications on the postoperative incidence of sinus rhythm and completeness of lesions performed.
MATERIAL AND METHODS: A total of 55 patients underwent concomitant atrial fibrillation surgical ablation using cryoenergy under various conditions: epicardially during cardiac arrest, epicardially on beating heart, and endocardially. In the postoperative period, patients were invited to attend an electrophysiological examination to assess the completeness of surgical ablation lesions and, if necessary, to complete catheter ablation.
RESULTS: Twenty-four patients underwent epicardial ablation on the arrested heart (group 1), 12 patients underwent epicardial ablation on the beating heart (group 2), and 19 patients underwent endocardial ablation (group 3). In the electrophysiological examination, sinus rhythm was present in 71% vs. 83% vs. 89% of patients, respectively. The completeness of pulmonary vein isolation was confirmed in 31% vs. 25% vs. 95% of patients, complete box lesions in 15% vs. 0% vs. 79% of patients, respectively.
CONCLUSIONS: Despite the similar clinical effect of surgical ablation in all three approaches, the morphologically most effective use of cryoenergy is endocardial ablation. This approach has a very good result. Our findings further support the endocardial use of cryoenergy during surgical ablation of atrial fibrillation.
Copyright © 2020 Polish Society of Cardiothoracic Surgeons (Polskie Towarzystwo KardioTorakochirurgów) and the editors of the Polish Journal of Cardio-Thoracic Surgery (Kardiochirurgia i Torakochirurgia Polska).

Entities:  

Keywords:  atrial fibrillation; cryoenergy; surgical ablation

Year:  2020        PMID: 32728360      PMCID: PMC7379213          DOI: 10.5114/kitp.2020.94188

Source DB:  PubMed          Journal:  Kardiochir Torakochirurgia Pol        ISSN: 1731-5530


Introduction

The Cox MAZE IV is the gold standard for surgical treatment of atrial fibrillation (AF) [1, 2]. However, since its introduction, many variations in the number and location of individual lesions and in the form of supplied energy have been described [3]. Cryoenergy, along with radio-frequency energy, is the most commonly used method of lesion formation in patients after surgical ablation of atrial fibrillation, with good and stable long-term results [4-6]. Despite frequent use, the clinical effect of cryoenergy in the endocardial and epicardial approaches is not sufficiently known. For these reasons, surgeons sometimes refuse to simultaneously add surgical ablation of AF to the main surgery. In clinical practice, many patients attending cardiac surgery with AF are not treated at all (up to 50%) [7].

Aim

The aim of this study was to compare the clinical effect of various cryoenergy applications on the postoperative incidence of sinus rhythm and the completeness of lesions performed.

Material and methods

This was a single-centre, prospective study. A total of 55 patients underwent surgical ablation of AF as part of another cardiac surgery procedure (myocardial revascularisation, valve surgery, combined procedure). Before the start of the study the authors obtained approval from the institutional Ethical Committee regarding the study design. The selection criteria were: AF refractory to at least one class I or class III antiarrhythmic therapy, concomitant cardiac surgery, absence of prior catheter ablation, and written, informed consent to study participation and postoperative electrophysiological examination. The standard surgical ablation protocol includes the isolation of the pulmonary veins and the formation of a box lesion by cryoenergy under various conditions – epicardially on extracorporeal circulation and cardiac arrest, epicardial on extracorporeal circulation on the beating heart, and endocardial. A Cardioblate® CryoFlex® surgical ablation probe, Medtronic, Minneapolis, USA was used to create the lesion. The standard duration of cryoenergy application was 2 minutes at –160°C. The electrical insulation of the lesions was not electrically verified during the operation. All of the patients underwent left atrial appendage occlusion using an Atriclip device. In the postoperative period, treatment of AF was as follows: all patients were on anticoagulant therapy with warfarin for 3 months. If they had AF during the postoperative period, they were pharmacologically treated with Cordarone or electroconversion, and patients were given oral Cordarone for 1 month after surgery. During the postoperative period, patients were invited to attend an electrophysiological examination to assess the completeness of surgical ablation lesions and, if necessary, to supplement the lesions with catheter ablation. All catheterisation procedures were performed using the CARTO3 mapping system. None of the patients was on anti-arrhythmic therapy during electrophysiological examination. If a normal sinus rhythm was present at the beginning of the procedure, RF ablation of the cavotricuspid isthmus was performed prior to initiation of left atrial ablation. The achievement of a bidirectional block of conduction through the isthmus was determined by standard criteria. Then, after double trans-septal punctures, two controllable trans-septal sheaths (8F, Channel, BARD Electrophysiology, Lowell, MA, USA) were introduced into the left atrium (LA), and a virtual anatomy reconstruction was performed, and a bipolar voltage map obtained at least 300 points for detailed mapping of the whole LA. A circular mapping catheter (LASSO®, Biosense Webster, Inc., Diamond Bar, CA, USA) was used in all veins to confirm isolation or electrical reconnection. RF energy was applied using a ThermoCool® Smart Touch™ catheter with a 3.5 mm irrigated tip (Biosense Webster, Inc.) and a software module that allows contact force sensing with a temperature limitation of 44°C and radio-frequency energy of up to 35 W. After reaching the insulation of all the veins (if they were reconnected), the posterior wall of the LA was mapped to confirm electrical insulation. For this purpose, the Lasso catheter was positioned so as to be perpendicular to the posterior wall. If no potentials were noted, the box lesion was considered present. If any potential was noted, both superior and inferior connecting lines were mapped to look for a gap. All gaps were subsequently ablated. Data were collected from the hospital medical electronic system and during postoperative controls by patients’ surgeons.

Statistical analysis

Data are presented as mean ± SD for continuous variables and percentages or numbers for categoric variables. Baseline clinical characteristics of patients were calculated.

Results

Twenty-four patients underwent epicardial ablation on the arrested heart (group 1), 12 patients underwent epicardial ablation on the beating heart (group 2), and 19 patients underwent endocardial ablation (group 3), as shown in Table I. The interval between cardiac surgery and electrophysiological examination was 144 ±138 days (group 1) vs. 178 ±84 days (group 2) vs. 102 ±76 days (group 3). During electrophysiological examination (Table II), sinus rhythm was present in 71% of patients 83% vs. 89% of patients in the groups 1, 2 and 3 (Figure 1). The completeness of pulmonary vein isolation was confirmed in 31% vs. 25% vs. 95% of patients and complete box lesion in 15% vs. 0% vs. 79% of patients, in the groups 1, 2 and 3 respectively (Figure 2).
Table I

Perioperative variables

ParameterEpicar-dially – Cx.Epicar-dially – no Cx.Endocar-dially
N241219
Mean age [years]72 ±873 ±570 ±4
Mean LA diameter [mm]48 ±549 ±448 ±4
LVEF (%)63 ±764 ±761 ±7
Persistent AFib (%)507568
CABG (%)374216
Valve (%)514273
Combined procedure (%)121611
ECC [min]9592114
Cx. [min]503581
Period SA-EP [days]144178102

LA – left atrium, LVEF – left ventricle ejection fraction, AFib – atrial fibrillation, CABG – coronary artery bypass grafting, ECC – extracorporeal circulation, Cx. – cross-clamp.

Table II

Findings during the electrophysiology examination

ParameterEpicar-dially – Cx.Epicar-dially – no Cx.Endocar-dially
LA volume [ml]141 ±30135 ±36144 ±22
Ablation of LAT11%8%11%
Ablation of RAT0%0%0%
Ablation of Aflut.17%17%0%
AT during testing31%33%14%
Procedure time [min]125120110
RF time [s]15351543771
RF applications (n)252613

LA – left atrium, LAT – left atrial tachycardia, RAT – right atrial tachycardia, Aflut. – atrial flutter, AT – atrial tachycardia, RF – time of radiofrequency ablation, RF – radiofrequency.

Figure 1

The incidence of sinus rhythm

Figure 2

The completeness of lesions

Perioperative variables LA – left atrium, LVEF – left ventricle ejection fraction, AFib – atrial fibrillation, CABG – coronary artery bypass grafting, ECC – extracorporeal circulation, Cx. – cross-clamp. Findings during the electrophysiology examination LA – left atrium, LAT – left atrial tachycardia, RAT – right atrial tachycardia, Aflut. – atrial flutter, AT – atrial tachycardia, RF – time of radiofrequency ablation, RF – radiofrequency. The incidence of sinus rhythm The completeness of lesions

Discussion

In the past, several articles were published dealing with the use of cryoenergy from the epicardial and endocardial approaches [6-16]. However, these studies were performed under laboratory conditions in an animal model, and the results were evaluated histologically in the acute phase of healing. Our work brings results from clinical practice, in which the structure of the left atrial wall is influenced by ongoing AF and the results of surgical ablation are evaluated electrophysiologically and along the entire length of the ablation line. There is also some time to create the scar after surgical ablation. This is one of the most accurate ways to evaluate the success of surgical ablation. According to available US registries, cryoenergy is used in approximately 30–50% of patients undergoing concomitant surgical ablation primarily from the epicardial approach [17]. Use of cryoenergy from the endocardial approach is an established method that encounters several obstacles: in patients without mitral and tricuspid valve defects, bicaval cannulation and opening on the left and right atria is necessary. This results in prolonged cardiac arrest interval, and a risk of air embolisation and postoperative bleeding. For these reasons, surgeons sometimes refuse to simultaneously add surgical ablation of AF to the main control. In clinical practice, many patients attending cardiac surgery with AF are not treated at all – up to 50% [17]. Our work also shows that the clinical effect of surgical ablation in terms of maintaining sinus rhythm in the postoperative period may not be identified with the completeness of surgical lesions. The incompleteness of surgical lesions may lead to a lower incidence of sinus rhythm in the postoperative period, and individual gaps in surgical lesions may have more proarrhythmogenic potential [18-20]. The limitations of this study are particularly evident in a small number of patients. However, our results may indicate a direction for further research into the surgical use of cryoenergy.

Conclusions

Despite the similar clinical effect of surgical ablation in all three approaches, the most electrophysiologically effective use of cryoenergy is endocardial ablation. This approach has a very good result. Our finding further supports the endocardial use of cryoenergy during surgical ablation of atrial fibrillation, and the results of this local study have led to changes in our workplace practices.
  20 in total

1.  Myocardial acute and chronic histological modifications induced by cryoablation.

Authors:  E Manasse; P Colombo; M Roncalli; R Gallotti
Journal:  Eur J Cardiothorac Surg       Date:  2000-03       Impact factor: 4.191

Review 2.  The technology in use for the surgical ablation of atrial fibrillation.

Authors:  Nicola Viola; Mathew R Williams; Mehmet C Oz; Niv Ad
Journal:  Semin Thorac Cardiovasc Surg       Date:  2002-07

3.  Epicardial beating heart cryoablation using a novel argon-based cryoclamp and linear probe.

Authors:  Federico Milla; Nikolaos Skubas; William M Briggs; Leonard N Girardi; Leonard Y Lee; Wilson Ko; Anthony J Tortolani; Karl H Krieger; O Wayne Isom; Charles A Mack
Journal:  J Thorac Cardiovasc Surg       Date:  2006-01-18       Impact factor: 5.209

4.  Effect of epicardial fat on ablation performance: a three-energy source comparison.

Authors:  Kimberly N Hong; Mark J Russo; Elyse A Liberman; Alex Trzebucki; Mehmet C Oz; Michael Argenziano; Mathew R Williams
Journal:  J Card Surg       Date:  2007 Nov-Dec       Impact factor: 1.620

5.  En bloc exclusion of the pulmonary vein region in the pig using off pump, beating, intra-cardiac surgery: a pilot study of minimally invasive surgery for atrial fibrillation.

Authors:  Gerard M Guiraudon; Douglas L Jones; Allan C Skanes; Daniel Bainbridge; Colette M Guiraudon; Steen M Jensen; Xiaping Yuan; Maria Drangova; Terry M Peters
Journal:  Ann Thorac Surg       Date:  2005-10       Impact factor: 4.330

6.  The concomitant cryosurgical Cox-Maze procedure using Argon based cryoprobes: 12 month results.

Authors:  N Ad; L Henry; S Hunt
Journal:  J Cardiovasc Surg (Torino)       Date:  2011-05-30       Impact factor: 1.888

7.  The Cox maze IV procedure: predictors of late recurrence.

Authors:  Ralph J Damiano; Forrest H Schwartz; Marci S Bailey; Hersh S Maniar; Nabil A Munfakh; Marc R Moon; Richard B Schuessler
Journal:  J Thorac Cardiovasc Surg       Date:  2011-01       Impact factor: 5.209

8.  Alternative energy sources for surgical treatment of atrial fibrillation in patients undergoing mitral valve surgery: microwave ablation vs cryoablation.

Authors:  Joon Bum Kim; Won-Chul Cho; Sung Ho Jung; Cheol Hyun Chung; Suk Jung Choo; Jae Won Lee
Journal:  J Korean Med Sci       Date:  2010-09-17       Impact factor: 2.153

9.  Epicardial treatment of atrial fibrillation using cryoablation in an acute off-pump sheep model.

Authors:  N Doll; P Kornherr; H Aupperle; A M Fabricius; B Kiaii; C Ullmann; K Schneider; S Dhein; H-A Schoon; A Rastan; T Walther; F W Mohr
Journal:  Thorac Cardiovasc Surg       Date:  2003-10       Impact factor: 1.827

10.  Surgical ablation for atrial fibrillation during isolated coronary artery bypass surgery.

Authors:  Piotr Suwalski; Mariusz Kowalewski; Marek Jasiński; Jakub Staromłyński; Marian Zembala; Kazimierz Widenka; Mirosław Brykczyński; Jacek Skiba; Michał Oskar Zembala; Krzysztof Bartuś; Tomasz Hirnle; Inga Dziembowska; Marek Deja; Zdzisław Tobota; Bohdan J Maruszewski
Journal:  Eur J Cardiothorac Surg       Date:  2020-04-01       Impact factor: 4.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.